Oxidative Stress Mediated by Macrophages Promotes Angiogenesis and Early Development of Endometriosis
article
OA: gold
CC0
AI-generated summary
Macrophages promote early endometriosis by mediating oxidative stress through Alox15 and HIF-1α signaling, which drives neovascularization and lesion growth.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a hormone-dependent gynecological disease manifested by cyclic pelvic pain and female infertility. Although many studies have shown that neoangiogenesis plays an essential role in the development of early endometriosis, the underlying pathophysiological mechanisms remain unclear. Recent evidence suggests that macrophages play an important role in the pathogenesis of endometriosis and that the hypoxia-inducible factor-1alpha (HIF-1α) may be involved, but when and how are largely unknown. Herein, we explore the role of macrophages in the early development of endometriosis using an in vivo subcutaneous implantation murine model. Upon depletion of macrophages, the subcutaneous injection of syngeneic endometrial material resulted in significant reduction in oxidative stress, endometriotic lesion size, and neovascularization. Likewise, inactivation of the lipid peroxidative gene Alox15 induced similar reduction in oxidative stress, lesion growth, and angiogenesis. Since HIF-1α is an important trigger of neoangiogenesis, we further administered a HIF-1α-specific inhibitor (PX-478) to our endometriotic model and further confirmed the same effects on the lesions. Taken together, these data suggest that an intact Alox15 pathway and HIF-1α signaling may play important roles in the macrophage-mediated oxidative stress and neovascularization of endometriosis in the early stages, suggesting anti-inflammation and antioxidation as potential therapeutic targets for the development of endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (56)
- Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Co‐culture with macrophages enhances the clonogenic and invasion activity of endometriotic stromal cells via openalex
- Evaluation of oxidative stress markers and intra-extracellular antioxidant activities in patients with endometriosis via openalex
- Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis via openalex
- Hypoxia: The force of endometriosis via openalex
- Immunobiology of endometriosis via openalex
- Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators via openalex
- Interferon‐Gamma (IFN‐γ) and Interleukin‐6 (IL‐6) in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Lgr5 Does Not Vary Throughout the Menstrual Cycle in Endometriotic Human Eutopic Endometrium via openalex
- Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo via openalex
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease via openalex
- Macrophages inhibit and enhance endometriosis depending on their origin via openalex
- MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target via openalex
- Oxidative stress and endometriosis via openalex
- Oxidative stress biomarkers in patients with endometriosis: systematic review via openalex
- Pathophysiology and Immune Dysfunction in Endometriosis via openalex
- Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice via openalex
- Real three‐dimensional approach vs two‐dimensional camera with and without real‐time near‐infrared imaging with indocyanine green for detection of endometriosis: A case‐control study via openalex
- Role of cytokines in endometriosis via openalex
- The link between immunity, autoimmunity and endometriosis: a literature update via openalex
- The Role of the Immune System in the Development of Endometriosis via openalex
- Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu via openalex
- Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis via openalex
- W2125884672 via openalex
- W2146408106 via openalex
- W2157354207 via openalex
- W2165623186 via openalex
- W2122386753 via openalex
- W2184888523 via openalex
- W2089190393 via openalex
- W2316741846 via openalex
- W2085010213 via openalex
- W2473287368 via openalex
- W2066383387 via openalex
- W2782685575 via openalex
- W2065377708 via openalex
- W1899746275 via openalex
- W2054472394 via openalex
- W2018504915 via openalex
- W2914782620 via openalex
- W2944542809 via openalex
- W2953909155 via openalex
- W2954780053 via openalex
- W2006760151 via openalex
- W1987320336 via openalex
- W3084507861 via openalex
- W1970676517 via openalex
- W3134885188 via openalex
- W3165294846 via openalex
- W3215893008 via openalex
- W1968265722 via openalex
- W1967769285 via openalex
- W4293162689 via openalex
- W4294243416 via openalex
- W4413115804 via openalex
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-05-18T00:30:19.791150+00:00
License: CC0
· commercial use OK